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ABSTRACT
THE INDIRECT EFFECT OF BVDV ON IMMUNE SUPPRESSION: THE ROLE
OF INFECTED MACROPHAGES IN LYMPHOCYTE APOPTOSIS
KARIM ABDELSALAM
2017
BVDV is an important pathogen of cattle that affects both the dairy and beef
industry causing severe economic losses. The main problem of BVDV is the immune
suppression that is associated with lymphoid depletion shortly post infection. The
mechanism of this immune suppression is not well understood. In this in vitro study, we
sought to determine the indirect effect of BVDV infection in macrophages as a key player
in the pathogenesis of BVD especially, the apoptotic effect induced on lymphocytes. We
infected bovine monocyte-derived macrophages (MDM) with either high or low virulent
strains of cytopathogenic or non-cytopathogenic strains of BVDV and collected
supernatants that were used for treatment of the fresh peripheral blood lymphocytes or
BL-3 B-cell line. We found that only supernatant from the high virulent BVDV strain
induced lymphocyte apoptosis. Furthermore, direct infection of lymphocytes with the
same virulent strain did not induce significant apoptosis. We investigated the apoptosisrelated cytokine profile of the infected macrophages by qRT-PCR with different BVDV
strains. There was no significant difference in the transcriptional profiles between strains
so cytokine induction does not seem to be a mechanism of induced apoptosis. We then
investigated the role of possible secreted viral proteins as the mechanism of indirect
apoptosis of lymphocytes by treating the supernatants with specific antibodies against
BVDV and its proteins. These treated supernatants still had lymphocyte apoptosis
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activity, ruling out their responsibility as well. Our data suggest an important role of
macrophages in the mechanism of lymphocyte depletion by high virulent strains of
BVDV, however further studies are required to determine the identity and mechanism of
action of these apoptotic factors present in the supernatant of the infected macrophages.
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CHAPTER 1
RESEARCH OBJECTIVES AND LITERATURE REVIEW
INTRODUCTION
BVDV is a viral pathogen of cattle and other ruminants that threatens both the
dairy and beef industry worldwide causing severe economic losses. Immunosuppression
attributed to lymphoid depletion is a major problem associated with BVDV. BVDV
associated lymphoid depletion following infection with highly virulent strain of BVDV is
often irreversible and leads to high mortality. The immunosuppression associated with
BVDV also interferes with the responses to vaccination. This BVDV associated
immunosuppression is not well-studied and further investigation still required.
RESEARCH GOAL AND OBJECTIVES
 The long-term goal of this research is to provide new insight about viral
pathogenesis and viral-host relationship for better understanding of the immune
suppression associated with BVDV. This was achieved by the following
objectives:
1. Investigate the direct and indirect effect of a highly virulent NCP BVDV
strain on total lymphocyte populations.
2. Investigate the apoptosis-induced-secretory-properties in the supernatant
of the macrophage infected with highly virulent NCP BVDV.
3. Perform cytokine transcriptional profiling of macrophages infected with
highly virulent BVDV strains.
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LITERATURE REVIEW

1. Biology of Bovine Viral Diarrhea Virus (BVDV)
1.1. BVDV Definition and Economic Importance
Bovine viral diarrhea virus (BVDV) is a pathogen that predominately affects
cattle throughout the world (Meyling et al., 1990). The emergence of more virulent forms
of the virus in the past few decades have made this a pathogen of increasing economic
importance (Goens 2002).
The overall effects of BVDV infection are difficult to examine, due to the breadth
of the disease. Research and data highlighting the effects of the disease is very limited,
simply due to the fact that too many variables are present for accurate measurement in
addition to lack of knowledge about its pathogenesis. Furthermore, with the worldwide
prevalence of BVDV, it is easily understood why BVDV infections have a huge
economic impact (Larson et al., 2004).
BVDV is a pantropic viral infection that affects reproduction and production in
addition to immunosuppression. Reproductive disorders caused include abortion, early
embryonic deaths, and fetal defects. Production effects are associated with decline in
feed-to-gain efficiency, lower carcass quality, and decreased milk production (Hafez,
1975). More importantly is the immune dysfunction caused by BVDV and consequently,
secondary bacterial infection and vaccination failure that will lead to continual spread of
the virus. The virus’ high prevalence rate, resultant abortions, persistent infections and
manifestations (i.e. mucosal disease) make prevention and active management of BVDV
essential for cattle producers (Ridpath, 2013).
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Despite the current vaccine control strategy that has been used for over 60 years,
significant economic losses from BVDV are still reported in the United States (Ridpath,
2012) and worldwide (Stahl and Alenius, 2012). BVDV infection of circulating white
blood cells may change their ability to stimulate adaptive immune responses and facilitate
chronic infection of these cells, thus contributing to the failure of the control strategy
(Givens and Marley, 2013). Previous studies on the economic impact of this virus on
cattle industry indicate that the estimated economic losses range up to $80 per head
(Table 1).
1.2. BVDV structure
BVDV is a small, enveloped, single-stranded, positive sense RNA virus of about
45-50 nm in diameter. The morphology of BVDV is pleomorphic but mainly spherical
(Coria et al., 1983; Collett, 1992). BVDV has an icosahedral capsid that is surrounded by
tightly adherent lipid bilayer envelope (5-7nm thickness) carrying on its surface
glycoprotein spikes (Figure 1.1.) (Thiel et al., 1996).
BVDV genome is a single positive sense infectious RNA with a single open
reading frame (ORF) bounded by 5' and 3' un-translated region (UTR). The actual length
of the virus genome is variable due to changes in the ORF region. The NCP SD-1 strain
is 12.3 kb in length (Collett, 1992) while the length of CP NADL and Osloss strains is
12.5 kb. These changes in the size of ORF have different forms including insertion,
deletion, rearrangement and duplication (Purchio et al., 1984).
The ORF encodes a single polyprotein of 3888 and 3998 amino acids for NCP
and CP biotypes respectively. This large polypeptide is proteolyticly processed during
virus replication to produce a variety of viral structural and nonstructural proteins
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(Murphy et al., 1999). These proteins beginning on the 5’ third of the virus include one
nonstructural protein; P20/NPRO followed by four structural proteins; P14/C, gp48/E0,
gp25/E1, gp53/E2, and the last three structural proteins forms envelope glycoprotein
spikes. The remaining of the ORF is translated to give other nonstructural proteins
(Figure 1.2.) (Deng and Brock, 1992).
1.2.1. The proteins encoded by BVDV genome:
The viral encoded proteins depend on the biotype of the virus: CP BVDV isolates possess
both the P80 and P125 while NCP display only P125 (Akkina, 1982). The genome of the
BVDV has a large ORF with a capacity to encode structural and nonstructural
polyprotein of 3898 amino acids and of a 438 kD protein (Deng and Brock, 1992). A total
of 10-13 virus-induced polypeptides have been identified in infected cells and CP BVDV
express one or more additional polypeptides (Collett et al., 1989)
Npro/P20 Npro is the first translation product of the ORF. This protein consists
of 168 amino acids, with an observed mass of 20 kD in SDS-PAGE. It is a cis-acting
papain-like protease that cleaves inter-molecularly at its C-terminus, releasing itself from
the nascent poly-protein. Npro then cleaves the large poly-protein into many structural
and nonstructural viral proteins. The functions of this papain-like protease in virus
replication include generation of the terminus of C (Rumenepf et al., 1998), as well as
specific blocking of the activity of interferon regulatory factor 3 (IRF-3), a transcription
factor essential for interferon promoter activation and so inhibition of IFN antagonistic
action on virus replication (Hilton et al., 2006)
C/P14 It is the second protein encoded and the first structural protein that
comprise the capsid protein of 102 amino acids weighting 14 kD. It is a well-conserved
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protein in most pestiviruses. The function of this protein is to package the genomic RNA
and to provide necessary interaction for formation of the enveloped virion. This protein is
weakly antigenic in cattle, as sera from convalescent cattle doesn’t contain antibodies to
C (Donis, 1995). However, when a recombinant adenovirus containing C was injected in
mice, high levels of humoral and cellular immune responses against C protein were
produced, indicating highly immunogenic in the mouse (Elahi et al., 1999).
Erns/E0/gp48 It is a glycoprotein of 227 amino acids with a MW of 44-48 kD for
the intracellular anchor protein, however another secreted form of Erns glycoprotein was
detected while migration on SDS PAGE with a molecular weight of 46-69 kD due to
glycosylation . Erns represents an unusual type of membrane anchor. Analyses with
different extraction procedures showed that Erns is neither easily stripped from the
membrane, like a peripheral membrane protein, nor as tightly membrane bound as a
transmembrane protein (Fetzer et al., 2005). The function of Erns is unclear but it appears
to have RNase activity and is thought to cleave RNA inside the cell. The entire Erns
protein is able to translocate into the cell. Furthermore, other proteins and even active
enzymes could be transported inside the cell when they were attached to the C-terminal
Erns peptide (Langedijk, 2002). This protein is highly conserved among different
pestiviruses. Although this structural protein is highly immunogenic, it produces limited
virus neutralizing antibody activity (Donis, 1995). On the other hand, Erns glycoprotein of
CSFV can be secreted and induce apoptosis in lymphocyte populations (Bruschke et al.,
1997). The variation in Erns glycoprotein will lead to diagnostic failure of BVDV by
different diagnostic techniques as indirect fluorescence assay (IFA), and enzymelinked
immunosorbent assay (ELISA) (Gripshover et al., 2007).
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E1/gp25 This glycoprotein has a MW of 21–25 kD and is ~195 amino acids in
length. This protein has 2 hydrophobic transmembrane portions that initiate translocation
of the adjacent polypeptide, E2. E1 is covalently linked with E2 by disulfide bonds
(Donis, 1995). The antibodies produced against this glycoprotein are not protective as the
level of antibodies against this protein in convalescent cattle were not significant.
However, this protein elicited monoclonal antibodies in mice (Kreutz et al., 2000).
E2/ gp 53 This glycoprotein is ~375-400 amino acids long and has a MW of 4145 kD. It contains three to four consensus sites for glycosylation and it is anchored in the
envelope as homo and heterodimers with E1. E2 is highly antigenic as it provokes the
production of neutralizing antibodies in the host after infection or vaccination (Donis,
1995).
NS2-3/P125 It is the biggest nonstructural protein and is a serine protease. It has
a MW of 125 kD and is composed of ~1300 amino acids. This protein is 2 polypeptides:
NS2 and NS3 (Donis, 1995). This protein plays an important role in virus replication as
well as induces a strong humoral immune response against it. The humoral immune
response induces a response to live attenuated vaccines but not against killed vaccines,
which is unable to replicate, suggesting its important role in replication. This complex
protein aided in the inhibition of IFN-beta production inside the cell. This inhibition of
the major anti-viral mechanism allows the rapid spread of the NCP strain and certainly is
one of the reasons that NCP BVDV is the major biotype in nature (Paton et al., 1991).
NS2/P54 This polypeptide is a product of the cleavage of NS23 and composed of
400 amino acids with a MW of 54 kD. This polypeptide doesn’t exist in all cytopathic
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isolates of BVDV (Donis, 1995). It is poorly immunogenic and doesn’t induce humoral
immunity in infected cattle (Bolin and Ridpath, 1989).
NS3/P80 It is a polypeptide of 80 kD found only in cytopathic strains, and is
considered a marker for cytopathogenicity. It is the most conserved protein in the genus
pestiviruses, it is very stable in infected cells and of high antigenicity (Donis, 1995). This
polypeptide is a multi-functional protein that helps in RNA replication and energy
production (Gu et al., 2000). Expression of NS3/4A resulted in increased activity of
caspase-9 and caspase-3, indicating induction of the intrinsic apoptosis pathway. A
mutation in NS3/4A without protease activity was unable to induce apoptosis, suggesting
that NS3 protease activity is required for initiation of apoptosis during CP BVDV
infection. This polypeptide is unable to inhibit TLR3- and RIG-I-dependent activation of
the IFN-beta promoter (Gamlen et al., 2010).
NS4A/P10, This polypeptide is composed of 55 amino acids with a MW of 10
kD. It is not immunogenic but seems to be well conserved among different pestiviruses
suggesting important role in replication (Donis, 1995). NS4A act as co-factor for
proteinase enzymatic activities of NS3 (Gamlen et al., 2010)
NS4B/P32, It is a polypeptide of 32 kD with a regulatory role in the protease
activity of NS23 in the generation of NS5B. It is not immunogenic, which is confirmed
by failure of infected cattle to produce NS5B antibodies (Donis, 1995). Induction of a
mutation in NS4B can attenuate BVDV cytopathogenicity despite NS3 production,
suggesting an important role in the replication of CP strains (Qu et al., 2001).
NS5A/P58, This polypeptide contains ~450 amino acids and has a MW of 58 kD.
NS5A is a phosphoprotein which has several roles in the Flaviviridae replication and
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cytopathogenicity (Majumder et al., 2001). Pestiviruses have split their RNA polymerase
activity into two polypeptides; NS5A and NS5B. No humoral immune response is evoked
against this protein in either infected or vaccinated animals (Donis, 1995).
NS5B/P75, This polypeptide has a molecular weight of 75 kD. It is the last
encoded nonstructural protein and has a putative viral RNA-dependent RNA polymerase.
It has the shortest half-life of all BVDV polypeptides. No serum antibodies can be
detected against this polypeptide (Zhong et al., 1998)
1.3. BVDV Taxonomy and Classification
BVDV has been recently classified in unassigned order, Family: Flaviviridae,
which contain 4 genera; Flavivirus, Hepacivirus, Pegivirus and Pestivirus, the latter
genus includes BVDV (ICTV 2015).
Genetic sequencing and analysis of 5' UTR of BVDV viral genome has
determined that there are two genotypes: type I and type II. BVDV type II lack an
internal Pstl restriction site that is present in 5' UTR of all BVDV type I isolates (Elahi et
al., 1999). Also, BVDV type I shows greater intragenotypic variability than BVDV type
II (Kwang et al., 1991; Lewis et al., 1991) (Figure 1.3.) and can be subdivided into many
subtypes BVDV (1a - 1u), while BVDV type II can be subdivided into only three
subtypes (2a - 2c) based on the difference in Npro and E2 sequences (Strong et al.,
2012;Liu et al., 2009; Mao et al., 2016). An unclassified atypical pestiviruses referred to
as Hobi-like BVDV (BVDV type III) has been identified that is phylogenetically distant
from BVDV-1 and BVDV-2. This virus is also antigenically distinct so BVDV-1 & -2
diagnostics and control strategies will be ineffective (Figure 1.3.) (Bauermann et al.,
2013).
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Each genotype can be further subdivided into 2 biotypes: cytopathic and noncytopathic strains according to its pattern of growth in cell culture. Most of the BVDV
isolates obtained from field cases are NCP in cell culture (Brock, 1995). On the other
hand, CP virus is associated with mucosal disease in PI animals; this will occur after the
superinfection with CP strain of PI animals, leading to fatal mucosal disease (Werdin et
al., 1989; Greiser-Wilkie et al., 1993). Recently another biotype of BVDV,
lymphocytopathogenic has been identified. These are NCP strains that induce apoptosis
in lymphocyte populations (Ridpath et al., 2006).

2. BVDV replication
2.1. Overview of virus replication
BVDV replicates efficiently in cells derived from order Artyodactyla, reflecting
the in vivo host range of the virus. Optimal replication takes place in bovine, ovine or
caprine cells, whereas replication is less efficient in swine cells (Bolin et al., 1994). The
replication of NCP-BVDV in cell culture of bovine origin causes no changes in these
cells (Moennig and Plagemann, 1992). Rabbits are susceptible to infection with rabbitadapted BVDV (Fernelius and Lambert, 1969). Mice also can be infected with BVDV by
intra-nasal and intra-peritoneal routes and the virus can be detected in spleen, lymphoid
tissue, the lungs and the stomach 7 days post infection but not in the liver and kidney
(Seong et al., 2015).

BVDV is one of the RNA viruses that is characterized by intracytoplasmic
replication with production of new progeny within 12 to 14 hours from the start of
infection (Moennig, 1990). Each infected cell produces 100 to 1000 complete infectious

10
virions (Donis, 1995). Not all susceptible cells will release new progeny. Bovine
macrophages are a good example; these cells are infected and the virus replicates with
new viral protein formation, but they fail to produce new progeny. The block in
production may be associated with the assembly or the release of the virus (Chase et al.,
2015)
2.2. Attachment and Penetration:
The initial trigger of endocytosis is the E2 spike interacting with a 50 kD cellular
receptor present on healthy susceptible cells (Xue and Minocha, 1993). It is important for
the susceptible cell not to be treated with any materials such as proteases as the latter
make the cells resistant for infection. The process of endocytosis is mediated by low
density lipoprotein (LDL) receptors on permissive cells as complete inhibition of this
kind of receptors will consequently the process of penetration. Further evidence is
provided by lack of LDL receptors on BVDV resistant cells (Agnello et al., 1999). The
Erns, E1, and E2 have important roles in virus binding and cell entry as well as for
immunologic recognition by the host. The E2 protein contains the major recognition sites
for BVDV neutralizing antibodies against BVDV. The neutralizing epitopes of E2 are
important targets for BVDV vaccine efficacy (Chimeno Zoth et al., 2007). Unlike E1 and
E2, Erns is dispensable for cellular entry (Ronecker et al., 2008). The E1 protein is
predicted to have various functions such as a membrane anchor for E2. The E1 and E2
form E1-E2 heterodimers. The E1-E2 heterodimers appears to be essential for cell entry
of BVDV (Rumenapf et al., 1993; Ronecker et al., 2008). After the process of entry,
uncoating of viral nucleic acid is achieved by the aid of acidic pH of cellular endosome
(Boulanger et al., 1992).
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2.3. Gene translation:
Translation of the viral genome requires partial stripping of the capsid protein C
from the RNA to start translation of the virus-encoded genes in the infected cells. The
process of translation begins when 5' UTR, which act as an internal ribosomal entry site
(IRES), that binds independently to ribosomal 40s subunit and eukaryotic initiation factor
(eIF) 3. Another important thing is that the 5' UTR contain determinants that mediate
direct attachment of 43S ribosomal complexes to the initiation codon (Pestova and
Hellen, 1999). The translation process yields a single polyprotein that can be detected in
foetal bovine testicles cells as early as 3 hours after infection, reaching a peak at 12 to 14
hours post infection (Donis and Dubovi, 1987). The 5' UTR encodes a bi-functional
secondary structure motif that enables the viral RNA to switch from the translation to the
replication cycle and vice versa (Yu et al., 2000 and Li and McNally, 2001).
2.4. Processing of BVDV polyprotein:
The polyprotein is subjected to 9 or 10 cleavage events that yield 4 structural and
8 nonstructural proteins (Wiskerchen and Collett, 1991; Akkina, 1991). Several
regulatory and catalytic intermediates are produced during polypeptide processing
(Chambers et al., 1990). The processing of the polyprotein starts with cleavage of
nucleocapsid protein (C) with Npro and Erns. Later, the amino-terminal end of C protein
is cleaved by a co-translational autoproteolytic event by Npro (Stark et al., 1993). This is
followed by cleavage of the C protein from Erns in the host cell’s endoplasmic reticulum.
The other structural proteins are cleaved by cellular proteases (Ronecker et al., 2008).
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2.5. BVDV genome replication:
Once the viral enzymes necessary for RNA replication are produced by
translation of BVDV genomic RNA and polyprotein processing, the viral life cycle enters
its RNA genome replication phase. Two well-defined processes are required to produce
identical copies of the incoming plus sense genomic RNA. First, a negative strand copy is
made to serve as template. Second, progeny viral RNA is synthesized using the template
from the previous step. Additional polypeptides are likely to participate in RNA
replication (Donis, 1995).
Experimental data demonstrate that the enzymatic activities located in C-terminal
portion of the NS3 protein, particularly the ATPase/RNA helicase, play a pivotal role
during early steps of the viral replication pathway (Gu et al., 2000). The prototype
replicon, BVDV D19c, containing the genomic 5' and 3' UTR and truncated ORF
encoding mainly the nonstructural proteins NS3, NS4A, NS4B, NS5A and NS5B was
used to study which proteins were essential for viral replication and whether they acted in
cis or in trans. Introduction of a large spectrum of in-frame mutations into the D19c ORF
was done. This suggested that the region from NS3 to NS5B played a pivotal role even
during the early steps of the viral replication pathway. Replication of functional and
nonfunctional NS5A mutants could be clearly enhanced and restored respectively
(Grassmann et al., 2001).
2.6. Assembly and release:
With the packaging of progeny RNA and assembly of virions, the replication cycle
enters its final stages. Signals for RNA encapsidation by C protein haven’t been defined,
however RNA binding sites on the C protein with specific structures on the viral RNA
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was considered necessary. Evidence from electron microscopic studies suggests that
BVDV assembly takes place in the ER or the Golgi. During this process, that likely
involves contact between C and the tail of E2, virions acquire a lipid envelope and
accumulate transiently in the lumen of vesicular transport (Donis, 1995). The BVDV
envelope glycoproteins, Erns and E2, as well as the nonstructural proteins, NS2-3 and
NS3, are highly associated with intracellular membranes. These finding indicate that
BVDV is released by budding into the cisternae of the endoplasmic reticulum (Grummer
et al., 2001).

3. Bovine Viral Diarrhea Virus Disease
3.1. BVDV infection strategies
BVDV is considered a successful virus from the epidemiological point of view
because of its ability to persist. This success leads to its worldwide distribution and high
rate of infection. The secret behind this success is a combination of two well-known
strategies, the “hit-and-run” strategy and the “infect-and persist” strategy. BVDV has the
ability to use a combination of both strategies in nature.
3.1.1. Hit and Run
The hit and run strategy is the most common strategy used by the virus. This
strategy involves a short period of susceptibility to infection in their host so that it can
multiply and survive, leading to a transient infection. Following the multiplying of the
virus the hosts develop antibodies to protect them from a repeat BVDV infection for the
rest of their relatively short life. By this strategy the virus relies on continuously finding
new susceptible hosts (Figure 1.4.) (Schweizer et al., 2006).
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3.1.2. Infect and Persist
The hit & run strategy is considered insufficient for the survival of BVDV, in
other words, without PI animals, the virus will disappear. BVDV has the ability to persist
in its host. The persistent infection caused by BVDV results when the noncytopathogenic virus evades the immune system of the host by infecting the pregnant
animal and then the fetus at the first trimester of pregnancy specifically from 30-110 days
of gestation prior to attainment of immune-competence. The fetus develops an
immunotolerance towards the virus (Figure 1.4.) (Ridpath, 2012).
3.2. BVDV Pathogenesis and Disease outcomes
Viral pathogenesis is the sum of its effects on host cellular protein function, gene
expression and the capacity of the host cell to maintain its integrity (Lyles, 2000).
BVDV is characterized by complex pathogenesis that is reflected in the wide variety of
clinical signs (Brownlie et al., 1984). Titration of different strains of BVDV on bovine,
ovine and porcine cells showed that pestiviruses infected bovine, ovine and porcine in a
like manner (Meyers et al., 1992).
During the acute infection, the initial infection takes place in the oronasal mucosa
and the virus spreads from this site systemically. BVDV invades the lymphoid tissue, and
disables the recognition of effector functions of immunity with subsequent capability of
persistence (Brownlie, 1990). Field strains capable of rapid growth in the oronasal
mucosa have been involved in the acute disease. Systemic spread of infection may occur
as free virus in serum or as virus associated with the cells in the blood; the lymphocytes
and monocytes are generally regarded as being particularly sensitive to BVDV infections
(Bruschke et al., 1998).
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After infection, BVDV antigen can be recovered from nearly all tissues and
different biotypes can be isolated from different sites, whether it is mucosal disease, acute
infection or persistent infection. However, in the case of mucosal disease, large amounts
of BVDV antigen were detected mainly in tissue samples from lymphoid and GI tissue,
with only small amounts in the respiratory tract. Generally, abundant NCP BVDV
antigen was detected in the pituitary gland, and in pancreatic Langerhans islets, whereas
cytopathic BVDV was isolated mainly from mesenteric lymph nodes and Peyer's patches
(Spagnuolo et al., 1997).
There is a difference in the virulence and pathogenesis of the BVDV that appears
to be strain and biotype dependent (Bolin and Ridpath, 1992). Both CP and NCP BVDV
biotypes were isolated from herds experience acute and chronic BVDV.
The two biotypes of BVDV also play an important role in creating MD (Brownlie,
1991). When the PI animal, initially infected with NCP biotype at early gestation,
becomes superinfected with CP strain leading to initiation of mucosal disease. This can
be ther result of spontaneous mutation from NCP to CP biotypes leading to development
of MD (Baker, 1995; Darweesh et al., 2015)
The degree of antigenic homology between the CP and NCP strains may be an
important factor in determining the pathogenesis of MD (Meyers et al., 1989, and
Shimizu et al., 1990). Acute fatal MD occurs when PI cattle are exposed to CP biotype
of the same genotype, that is to say homologous biotypes, however if the PI cattle are
exposed to a heterologous CP strain of different genotype, chronic MD may develop
instead (Baker, 1995). The level of circulating gamma-delta T cells might also determine
whether or not PI animals develop MD (Bruschke et al., 1998).
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The type of clinical response to infection with BVDV is variable and
multifactorial. It depends on several factors such as, the immune status, pregnancy status
and the age of the fetus as well as concurrent level of environmental stress (Bolin and
Ridpath, 1992).
3.3. BVDV-induced Immunosuppression:
The virus appears to be able to replicate in all of the major lymphocyte
subpopulations as well as in accessory cells. This may result in the leukopenia that is
often a sequel of infection and affects B-cells as well as the T-cell sub-populations
expressing either BoCD4 or BoCD8 antigens. B and T-cell responses are affected as a
consequence of exposure to BVDV and there is a reduced ability to control other
infections. Although the fetus can mount an immune response in the latter part of
gestation, during the first trimester it does not. A specific state of tolerance is induced and
this is associated with change in the proportion of certain lymphocyte subpopulations and
ability to respond to immune stimulation (Howard, 1990).
Non-cytopathic BVDV fails to induce interferon type I in cultured bovine
macrophages whereas cytopathic biotypes readily trigger this response. Cells infected
with non-cytopathic BVDV are also resistant to induction of interferon by double
stranded RNA, a potent interferon inducer signaling the presence of viral replication in
the cell (Schweizer and Peterhans, 2001). Thus, non-cytopathic BVDV may dispose of a
mechanism suppressing a key element of the antiviral defense of the innate immune
system. Since interferon is also important in the activation of the adaptive immune
response, suppression of this signal may be essential for the establishment of persistent
infection and immunotolerance (Peterhans et al., 2003).
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The level of suppression of the adaptive immune response is strain-dependent.
Non-cytopathic (NCP) BVDV infection stimulates cytokines from macrophages in vitro
but the effect of BVDV infection in vivo on macrophages or in vitro with monocytes is
not clear. Antigen presentation is decreased and co-stimulatory molecules are down
regulated. T-lymphocytes numbers are reduced following BVDV infection in a straindependent manner. There is recruitment of lymphocytes to the bronchial alveolar space
following cytopathic (CP) BVDV infection. Depletion of T-lymphocytes occurs in the
lymphoid tissue and is strain dependent. BVDV CP T-lymphocyte responses appear to be
primarily a T helper 1 response while the response following NCP BVDV induces a T
helper 2 response. (Chase, 2013).
Many immune cells are susceptible to BVDV infection including monocyte and
granulocytes. This infection is associated with reduction of their functions. BVDV
infection leads to severe reduction in lymphocyte population as it affects both thymic and
follicular T-lymphocytes (Brewoo et al., 2007).
Acute BVDV infection or vaccination with modified live BVDV vaccine results
in decreased delayed type hypersensitivity T cell response to Mycobacterium avium and
Mycobacterium paratuberculosis purified protein derivative (Thoen and Waite, 1990).
Infection of calves with non-cytopathic viral diarrhea virus (BVDV) resulted in the
temporary suppression of lymphocyte proliferation and interferon-gamma production
leading to vaccination failure against other infectious agents (Charleston et al., 2001).
MLV BVDV vaccination resulted in the inhibition of antibody-dependent cellular
cytotoxicity by neutrophil (Roth and Kaeberle, 1983). The BVDV-infected monocytes
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reduced leukotriene B4, an important mediator for the production of some proinflammatory cytokines as IL-1, IL-2 and IFN-alpha (Atluru et al., 1992).
Unlike NCP strains, CP BVDV up-regulate both IFN type I and IL-12 within 1 h
post infection of monocyte. Both IFN-γ and IL-12 are secreted by NK cells and T cells.
The IL-12 acts as a growth factor for activated NK cells and T cells and enhances the
cytotoxic activity of NK cells and favors cytotoxic T lymphocyte generation (Abbas et
al., 1996; O'Garra, 1998; Trinchieri, 1995; Kalinski et al., 1999).

4. BVDV Immune Response
4.1. Immunology to natural infection:
Infection of normal calves with bovine virus diarrhea virus (BVDV) is a transient
self-limiting infection that can result in a period of immunosuppression (Howard, 1990).
Both humoral and cellular immune responses following natural infection are protective.
The majority of the B cell response (as measured by serum antibodies) is directed against
the viral proteins E2 and NS2/3, with minor responses against the Erns and E1 proteins.
The major neutralizing epitopes are conformational and are located within the N-terminal
half of the E2 protein (Ridpath, 2013).
E2 induces neutralizing antibody in experimental and natural hosts. Moreover,
neutralizing antibodie raised against E2 are able to protect susceptible hosts from
infection with BVDV (Ferrer et al., 2007; Rosas et al., 2007; Thomas et al., 2009). The
induced antibodies against BVDV result in a 4-fold rise 2-4 weeks post infection. The
response is detected at a peak 8 to 10 weeks up to 1 year after infection then the antibody
levels decrease very slowly (Howard, 1990). The heterogeneity that exists among
circulating BVDV strains prevents protective cross immunity (Ridpath, 2013).
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4.2. BVDV maternal immunity:
Calves receive maternal antibodies via colostrum uptake. In the first weeks of life,
these antibodies prevent a BVDV infection. Protection lasts approximately 6 months, and
even as long as 9 months (Munoz et al., 2002). Passive maternal antibodies protect
against nasopharyngeal shedding of the virus, and reduce leukopenia in challenge
inoculated calves (Howard et al., 1989). The mean half-life of maternal antibodies in nonvaccinated calves to BVDV1a, BVDV1b, BVDV2 was 23.1, 22.8, 22.9 days respectively.
The mean half-life of viral antibodies was greater for vaccinates than for nonvaccinates
for BVDV. The calculated mean time to seronegative status for nonvaccinates based on
titers at day 0 was: BVDV1a, 192.2 d; BVDV1b, 179.1 d; BVDV2, 157.8 days (Fulton et
al., 2004).
Interference by maternal antibodies prevents the development of an antibody
response following vaccination with most of killed and attenuated BVDV vaccine with
exception to adjuvant based killed vaccines. However, T cell mediated immune response
to BVDV may be generated in the absence of a detectable serum neutralizing antibody
response. Vaccinating young calves against BVDV while maternal antibody is present
may generate BVDV specific memory T; CD4+, CD8+, and gamma delta T cell
responses as well as B cells. Seronegative calves with memory T and B cells specific for
BVDV may be immune to challenge with virulent BVDV (Endsley et al., 2003;
Zimmerman et al., 2006; Platt et al., 2009 ).
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4.3. Immunology to vaccinated animals:
Both modified live and killed vaccines are efficacious under controlled
conditions. Both humoral and cellular immune responses are protective. Following
natural infection or vaccination with a modified live vaccine, the majority of the B cell
response, as measured by serum antibodies, is directed against the viral proteins E2 and
NS2/3, with minor responses against the Erns and E1 proteins. Thus, E2 glycoprotein
constitutes an excellent candidate for the development of an experimental subunit
vaccine. Vaccination with killed vaccines results in serum antibodies directed mainly at
the E2 protein. Vaccination, while not 100% effective in every individual animal, is
effective at the herd level (Ridpath, 2013).
4.4. Immunology of PI animal:
PI animals develop neither neutralizing nor non-neutralizing antibodies against
BVDV, due to specific B and T lymphocytes immunotolerance (Larsson and Fossum,
1992). Sometimes, PI animals develop low titers of antibody that continue to decrease
with time. The presence or absence of neutralizing antibody in PI animals probably based
on the stage of pregnancy and the involvement of maternal previously present maternal
antibodies (Kane et al., 2015). However, it is considered as immunocompetent against
other viruses (Houe and Heron, 1993). Ingestion of colostrum to PI animal seems not to
be helpful any more rather it interferes with the initial isolation of the virus. Passively
derived BVDV antibodies decrease more rapidly in PI calves than in immunocompetent.
It was shown that this immunotolerance is highly specific: immunotolerant animals, upon
infection with a sufficiently different type of BVD/MD virus, develop an immune
response against that virus without, however, being protected against their “own” virus,
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i.e. the immune system is capable of differentiating between sufficiently distinct types of
virus (Chase et al., 2004). BVDV uses the macrophage/dendritic cell as a ‘lymphocyte
hitman’ that will help with lymphocyte apoptosis (Chase et al., 2015).
4.5. BVDV associated lymphoid apoptosis
BVDV is associated with immune suppression due to lymphoid depletion that can
be mild to severe, with variable levels of recovery depending on the virulence of the
BVDV strains (Ammari et al., 2012; Falkenberg et al., 2014; Liebler-Tenorio et al.,
2003). Interestingly, this lymphoid depletion was associated with increased number of
macrophages 3 days post infection in lymphoid tissues. The presence of this significant
number of macrophages in the lymphoid tissues suggests an indirect effect of this cell on
the lymphoid depletion caused by BVDV (Pedrera et al., 2009).
Previously, the same scenario has been proposed for the pathogenesis of classical
swine fever virus (CSFV), another member of the pestivirus group in the Flaviviridae.
CSFV can induce lymphoid apoptosis directly and indirectly via macrophages. With
CSFV, TNF-a production has induced apoptosis (Choi et al., 2004). The Erns protein of
CSF is responsible for lymphocytic apoptosis (Bruschke et al., 1997). Recently, the
involvement of apoptosis-induced cytokines, TNF-a and IL-1a, have been ruled out from
BVDV pathogenesis (Pedrera et al., 2009). Furthermore, the role of macrophages could
be only restricted to phagocytosis of apoptotic cell debris (Raya et al., 2012). Other
groups have suggested that most of the cells undergoing apoptosis after CP BVDV
infection are monocytes. Also CP BVDV can induce apoptosis in purified CD4 T
lymphocyte, which was enhanced by the presence of monocyte in a mixed population
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unlike CD8 T cells that undergo apoptosis only in a mixed population with monocyte
(Lambot et al., 1998).
Generally, there are 2 main pathways for induction of apoptosis: intrinsic and
extrinsic pathway, The apoptosis induced by cytopathic BVDV is associated with the
intrinsic but not the extrinsic pathway, especially due to the lack of caspase-8 expressio,n
which is the main mediator for extrinsic pathway whereas caspase-9, which is important
mediator of intrinsic pathway, was strongly expressed (Hilbe et al., 2013). Besides the
two biotypes of BVDV, CP and NCP, a third biotype has been proposed, which is
lympho-cytopathogenic and is associated with highly virulent strains. This third biotype
is includes highly virulent NCP biotypes that don’t induce CPE on cultured susceptible
cells but induce apoptosis in cultured lymphoid cells (Ridpath et al., 2006). There are
many differences present between the 2 biotypes of BVDV that may affect the
mechanisms of viral pathogenesis. There are around 26 genes differentially expressed
between CP and NCP BVDV in the infected cell (Werling et al., 2005). Cytopathogenic
BVDV exert its cytopathic effect on the susceptible cells via apoptosis, moreover, it has
been proposed that this apoptosis is associated with the direct effect of the virus on the
infected cell rather the interaction between infected and normal cell. Moreover, only CP
but not NCP strains can induce direct apoptosis to PBMCs (Zhang et al., 1996)(Lambot et
al., 1998).
Previous literature has proposed many hypotheses for the apoptotic ability of
cytopathogenic BVDV. Some researchers suggested the involvement of NS3 as one of
the main difference between CP and NCP BVDV. This is along with higher levels of
RNA accumulation in CP BVDV-infected cells than NCP BVDV-infected cells (Vassilev
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and Donis, 2000). The correlation between apoptosis and cytopathogenic effect of the
virus was confirmed later by other group that discussed the role of apoptosis inhibitors in
delaying the cytopathogenic effect of BVDV (Grummer et al., 2002).
Unlike CP BVDV, the NCP BVDV inhibits both IFN I synthesis and RNA
accumulation and the subsequent induced apoptosis in the infected cell. It has been
thought that this inhibition is mediated through the specific interfering with the
intracellular action of accumulated ds RNA but not with its uptake into the cells
(Schweizer and Peterhans, 2001).
Interestingly, the infection of monocyte/macrophage with CP BVDV leads to upregulation of crucial chemokines of CCL and CXCL families that are important in
induction of proper immune response against the infection. In contrast. NCP BVDV
down-regulated such important chemokines (Burr et al., 2012). Proper activation of
PBMCs in response to BVDV infection can protect them against apoptosis via TRAF2
dependent CD 28-4-1BB signaling (Song et al., 2016).
4.6. Immune cells associated with this BVDV study
This study was concerned with determining the direct and/or the indirect effect of
BVDV on lymphocyte populations. To study the indirect effect, the monocyte-derived
macrophages (MDM) were infected first with different strains of BVDV and the
irradiated infected supernatant were incubated with lymphocyte populations that were
collected from the blood or obtained from bovine lymphosarcoma cell line (BL-3).
4.6.1. Bovine monocyte derived macrophages (MDM)
Bovine macrophages are an important antigen presenting cell that is responsible
for uptake of infectious agents and processing the antigen for the effector immune cells to
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exert its specific immune mechanism to clear the infection. Macrophages originate from
hematopoietic stem cells and myeloid progenitor cells present in the bone marrow.
Monocytes, the progenitor for macrophages develop from myloid stem cells in the bone
marrow. The monocytes traffic from into the tissues to differnetiate into professional
macrophages (Chase et al., 2015). The number of macrophages as well as dendritic cells
increased in lymphoid tissue 3 days post infection. This increase maybe the result of
antigen presenting role, cell debris phagocytosis role or indirect apoptotic role of
macrophages especially since their presence was associated with severe lymphoid
depletion (Ridpath et al., 2006).
Macrophages are an important innate immune cell in the pathogenesis of BVDV.
Unlike monocyte, macrophages failed to produce BVDV new progeny after infection
however the virus that can replicate and synthesize its viral proteins (Chase et al., 2015).
BVDV infection doesn’t affect the viability of MDM in vitro (Chase et al., 2004; Rajput
et al., 2014). Interestingly, the macrophages and dendritic cells surrounding the apoptotic
lymphocytes in the lymphoid tissue don’t seem to be infected with BVDV (Liebleret al.,
2003). In vitro infection of cultured macrophage with BVDV was associated with
increased level of IL-1 and IL-6 but not TNF- α (Peterhans et al., 2003)
4.6.2. Bovine total lymphocyte population
Total peripheral blood lymphocyte populations include both specific T and B
lymphocyte. T lymphocytes and its subpopulations is important for induction of cell
mediated immune response against BVDV infected cells. While B lymphocytes are
responsible for induction of humoral immune response against BVDV mediated via the
production of neutralizing antibodies. Both humoral and cell mediated immune response
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is very important for viral clearance from the animal post-infection. In vitro infection of
peripheral blood lymphocytes with BVDV leads to induction of apoptosis in these cells
based on the virulence of the infecting strain. Moreover, in vivo BVDV infection results
in lymphoid depletion recoverable that may or may not be reversible based on the
virulence of BVDV strain. (Ridpath et al., 2006; Chase, 2013).
4.6.3. Bovine lymphosarcoma cell line (BL-3)
Bl-3 is a non-adherent cell line derived from BL-3.1 cell line that was obtained from
the American Type Culture Collection (ATCC, Manassas, VA). This BL-3.1 was
originally derived from a Hereford calf suffering from B cell lymphosarcoma (Theilen et
al., 1968). This cell line obtained from ATCC was infected with BVDV. The Bl-3 clone
used in this study does not produce bovine leukemia virus (Harms and Splitter, 1992).
The problem of BVDV contamination was solved using limiting dilution cloning to
produce a BVDV-free BL-3 cell line. All clones were examined for BVDV and proven to
be BVDV free by RT-PCR and immunohistochemistry following two blind passages of
cell lysates on MDBK cells (Falkenberg et al., 2014)

5. Control and prophylactic measures for BVDV:
Bovine viral diarrhea virus has important characteristics including genetic diversity
and a persistently infected that makes its control difficult in cattle populations. A
systematic control program that utilizes diagnostic strategies to find and remove PI cattle,
vaccination to increase fetal protection from infection, and biosecurity to reduce the risk
of exposure to animals persistently or transiently infected with the virus is necessary for
control of BVDV (Ridpath, 2013).
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5.1. Control strategies regarding the risk of PI calves:
Because the PI animal is an important reservoir and transmitter of BVDV, control
programs must first identify and remove these animals from the breeding herd. Exposing
a breeding herd to PI cattle is likely to cause transient BVDV infections of susceptible
cows and if pregnant, the subsequent vertical transmission of BVDV to their fetuses. To
prevent contact with pregnant cows, PI animals should be removed prior to the start of
the breeding season. To find and remove PI cattle prior to the start of the breeding season,
all calves, all replacement heifers, all bulls, and all non-pregnant dams without calves
(due to not becoming pregnant, aborting, or calf mortality) must be tested for PI status.
Any female that is pregnant at the time the herd is tested should be isolated from the
breeding herd and kept isolated until her calf is tested and found to be negative (Kelling
et al., 2000).
Once a calf is identified as PI, it should be euthanized or removed for slaughter
and the dam should be tested. Most dams of PI calves are not PI themselves, and if
confirmed as non-PI, can re-enter the breeding herd because naturally acquired immunity
is considered to be good protection from future fetal infections. Dams identified as a PI
should be slaughtered immediately. (Orban et al., 1989).
In whole herd testing, IHC testing of skin samples is the test of choice because it
can be accurately performed on animals of any age and a single sample is all that is
usually needed. Other tests can be used for confirmatory testing for presumptive positive
results from IHC when the history or clinical presentation does not concur with a
diagnosis of PI. Using virus isolation or PCR to identify PI cattle requires a second test at
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least three weeks following any positive samples to differentiate between transient
viremia and PI with BVDV (Ridpath, 2013).
5.2. Vaccination as a prophylactic measure:
Application of a vaccination protocol is necessary to reduce the risk of fetal
infection in the event of cowherd exposure to a viremic and shedding animal. Live,
replicating vaccines (MLV) have inherent properties that may enable them to stimulate
more complete protection against trans-placental infection. For that reason, one
recommendation is to vaccinate unstressed, healthy heifers with MLV vaccine. Vaccine
administration should be timed so that a protective immune response coincides with the
first four months of gestation. This is done to maximize the potential for adequate
immunity to protect against fetal infection and reproductive failure or the birth of PI
calves. In heifers not previously vaccinated, the primary vaccine series should consist of
two doses. The first dose should be given when the heifers are six months of age or older,
and the second dose should be given two months before breeding. Beef cows should be
revaccinated annually before breeding according to label directions (Kelling, 1996).
In vitro work has indicated that although there were large variations in the
vaccine-induced virus neutralizing titers of individual colostrum-deprived calves
vaccinated with two doses (21 days between doses) of an inactivated BVDV vaccine or a
modified live, temperature sensitive BVDV vaccine, serum from each animal was
capable of neutralizing a wide range of antigenically diverse European and American
isolates of BVDV, including genotypes I and II (Hamers et al., 2001). Other work has
shown that administration of a single dose of a modified live vaccine against BVDV
stimulated an antibody response in seronegative cows that was detectable for at least 18
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months. These antibodies were able to cross neutralize 12 antigenically diverse strains of
BVDV (Makoschey, 2001).
Efficacy of maternal vaccination to provide fetal protection when the dams were
experimentally challenged ranges from 25% to 100% for inactivated vaccines (Brownlie
et al., 1995), and from 58% to 92% for modified live vaccines (Dean et al., 2003). Dams
have measurable levels of anti-BVDV antibody following vaccination and fetal
protection appears to be improved by vaccination, making a planned vaccination program
important for BVDV control. However, a sufficient amount of virus is able to escape
inactivation by circulating antibodies in some dams to cause transplacental infection,
abortion, and the development of persistent fetal infection, making vaccination programs
inadequate to control BVDV by themselves (Brownlie et al., 1998).

SUMMARY
BVDV is an immune suppressive viral agent that is associated with immune
dysfunction in the infected animals. This immune dysfunction is mainly due to severe
lymphoid depletion associated with high virulent strains of BVDV. The mechanism that
explains this lymphoid depletion and the involvement of macrophages in such
mechanism is still ambiguous. The aim of this study was to explore the role BVDVinfected MDM in lymphocyte apoptosis and to shed light on possible new mechanisms
by which BVDV immune suppression can be explained.
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Figure 1.1. The Structure of BVDV. Adapted from ViralZone 2010, Swiss Institute of
Bioinformatics http://viralzone.expasy.org/all_by_protein/39.html
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Figure 1.2. Schematic representation of BVDV encoded proteins. Adapted from ViralZone
2008, Swiss Institute of Bioinformatics.
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Figure 1.3. Phylogenetic tree showing the difference between the three genotypes of BVDV
(Adapted from Decaro et al., 2012)
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Figure 1.4. Strategies of BVDV infection. Adapted from Institute of Veterinary Virology,
University of Bern http://www.bvd-info.ch/veterinarians/types_of_infection.html
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Table 1.1. The economic impact of BVDV. Adapted from ADM Animal Nutrition 2005
http://www.admsecondcrop.com/Beef/Beef%20Technical%20Bulletins/Beef%20BVDV%20Vira
l%20disease%20bovine%20viral%20diarrehea.htm
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CHAPTER 2
THE INDIRECT EFFECT OF BVDV ON IMMUNE SUPPRESSION: THE ROLE OF
INFECTED MACROPHAGES IN LYMPHOCYTE APOPTOSIS
ABSTRACT
BVDV is an important pathogen of cattle that affects both the dairy and beef
industry causing severe economic losses. The main problem of BVDV is the immune
suppression that is associated with lymphoid depletion shortly post infection. The
mechanism of this immune suppression is not well understood. In this in vitro study, we
sought to determine the indirect effect of BVDV infection in macrophages as a key player
in the pathogenesis of BVD especially, the apoptotic effect induced on lymphocytes. We
infected bovine monocyte-derived macrophages (MDM) with either high or low virulent
strains of cytopathogenic or non-cytopathogenic strains of BVDV and collected
supernatants that were used for treatment of the fresh peripheral blood lymphocytes or
BL-3 B-cell line. We found that only supernatant from the high virulent BVDV strain
induced lymphocyte apoptosis. Furthermore, direct infection of lymphocytes with the
same virulent strain did not induce significant apoptosis. We investigated the apoptosisrelated cytokine profile of the infected macrophages by qRT-PCR with different BVDV
strains. There was no significant difference in the transcriptional profiles between strains
so cytokine induction does not seem to be a mechanism of induced apoptosis. We then
investigated the role of possible secreted viral proteins as the mechanism of indirect
apoptosis of lymphocytes by treating the supernatants with specific antibodies against
BVDV and its proteins. These treated supernatants still had lymphocyte apoptosis
activity, ruling out their responsibility as well. Our data suggest an important role of
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macrophages in the mechanism of lymphocyte depletion by high virulent strains of
BVDV, however further studies are required to determine the identity and mechanism of
action of these apoptotic factors present in the supernatant of the infected macrophages.
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INTRODUCTION
BVDV causes immune dysfunction that affects cattle and other ruminant that
disrupt the current vaccination-based control strategy and cause severe economic losses.
The immune dysfunction associated with BVDV is multifactorial but one of the
mechanisms is believed to be a consequence of lymphoid depletion that could be mild or
severe based on the virulence of BVDV strains. The lymphoid depletion in some cases is
so severe with some high virulent strains that animals never clinically recover and either
die or are stunted (Ammari et al., 2012; Falkenberg et al., 2014; Liebler-Tenorio et al.,
2003). The exact mechanism by which BVDV exerts its apoptotic effect is not well
understood. Several studies suggest the possible role of macrophages in lymphoid
depletion and immune dysfunction associated with BVDV. These studies demonstrated
the importance of monocytes in lymphocyte apoptosis in a mixed population of monocyte
and lymphocytes (Pedrera et al., 2009, Lambot et al., 1998). However, the role of
apoptotic-associated cytokines, which are important as the mechanism of action for
lymphocyte apoptosis for CSFV, does not appear to be important for BVDV (Pedrera et
al., 2009). It has also been hypothesized that the pestivirus specific secreted Erns
glycoprotein (Fetzer et al., 2005) could play a role in the apoptosis mechanism associated
with CSFV (Bruschke et al., 1997).
Only CP but not NCP strains can induce direct apoptosis to PBMCs (Zhang et al.,
1996, Lambot et al., 1998). However most severe immune dysfunction due to BVDV
infection is caused by non-cytopathogenic strains and associated with severe lymphoid
depletion (Falkenberg et al., 2014). It has been proposed that NCP high virulent 1373
strain should be considered as lympho-cytopathogenic biotype since this virulent strain
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doesn’t induce CPE on the susceptible cell lines but can induce lymphocyte apoptosis 3
days post infection (Ridpath et al., 2006).
To investigate the direct and indirect effect of different strains of BVDV on
lymphocytes apoptosis, two types of lymphocytes were used. The first one was fresh
lymphocytes from peripheral blood that included B, T and gamma-delta T specific
lymphocytes in addition to NK cells. The second source of lymphocytes was BVDV-free
BL-3 cell line that is a non-adherent B cells that is derived from BL-3.1 cell line obtained
from the American Type Culture Collection (ATCC, Manassas, VA) (Falkenberg et al.,
2014). The direct apoptotic effect of BVDV was examined by direct infection of
lymphocytes with different BVDV strains. The indirect effect was investigated by
infection of the MDM with three different strains of BVDV for 2 different time points
followed by treatment of lymphocytes with the irradiated supernatant of infected
macrophages (Elmowalid, 2003). Parallel to that the apoptosis-related cytokine profile of
the infected MDM with different strains of BVDV has been studied.
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MATERIALS AND METHODS
Animals
Six healthy Holstein Friesian calves (6-8 months of age) housed at Dairy Farm,
South Dakota State University (SDSU), Brookings, SD, USA were used in this study.
The SDSU Institutional Animal Care and Use Committee approved animal handling and
blood collection. The animals were confirmed as BVDV-free by virus isolation followed
by immunoperoxidase assay (IPA) (Fulton et al., 1997)
Virus
Three strains of BVDV were used in the current study: BVDV 2a high virulence
1373, BVDV 2a low virulence 28508 and 296C (Ridpath et al., 2016). These strains have
been used before in examining the direct apoptotic effect of the virus. These strains were
already prepared as lab strains and were preserved at -80 (Table 2.1.). All strains were
titrated using TCID50 titration assay (Reed and Muench, 1938). Briefly, MDBK cells
cultured in T 75 flask were trypsinized followed by culturing of the disaggregated cells
into 96-well plate at a seeding density of 5x104 cell suspended in180 µl MEM / well. The
virus then diluted in 10-fold serial manner simply by adding 20 µl of the virus to each
well in the first column followed by mixing with 180µ cell suspension and transferring
that to the next column. The last 2 columns were kept uninfected as a negative control.
The infected cells were incubated at 37°C in a humidified CO2 incubator for next 3-4
days (Nuaire, NU 2700). For the CP strain, the plate was examined every day for CPE of
the virus. The highest dilution showing CPE was used as an endpoint to calculate virus
titer based on Reed and Muench equation (Reed and Muench, 1938) as follows:
TCID50/ml= (PD – log dilution above 50%) x 50
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Whereas, PD= proportionate distance that can be calculated using the following
equation: Proportionate distance (PD) = [(% CPE at dilution above 50%) – (50%)]/ [(%
CPE at dilution above 50%)- (% CPE at dilution below 50%)]
For NCP BVDV, the endpoint was determined by immunoperoxidase assay
(Fulton et al., 1997) with some modifications in the reagents used. Briefly, infected
MDBK cells were stained with 15c5 Erns specific monoclonal antibody (IDEXX
Laboratories, Westbrook, ME, USA) followed by biotinylated rabbit anti-mouse IgG
(Zymed, Invitrogen, Frederick, MD, USA), Streptavidin-HRP (Invitrogen, Camarillo,
CA, USA) and AEC reagent (3 amino-9 ethyl-carbazole) (Sigma-Aldrich, St. Louis, MO,
USA). The endpoint for NCP BVDV was determined by the presence of red stained cell
showing BVDV protein.
Madin Darby bovine kidney (MDBK) cells
BVDV-free MDBK cells (passage 113-135) were grown in minimal essential
medium (MEM, Gibco BRL, Grand Island, NY) (pH 7-7.4) supplemented with 10%
BVDV-free fetal bovine serum (FBS) (Hyclone Laboratories, Logan, UT), penicillin (100
U /ml) and streptomycin (100 μg /ml). MDBK cells were maintained at 37°C with 5%
CO2 in humidified incubator and were used for viral titration and propagation.
Isolation of peripheral blood mononuclear cells
Peripheral blood mononuclear cells (PBMC) were isolated as previously
described (Rajput et al., 2014) with modifications. Briefly, 120 ml of heparinized blood
was collected by jugular venipuncture from 6-8 month heifers, using a 60 ml syringe
containing 1 ml of 1000 U/ml heparin sulfate (Sigma, Sigma Chemicals, St. Louis, MO,
USA). The heparinized blood was diluted 1:1 with PBS and overlaid on SepMate™
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lymphoprep 50 ml tubes (Stemcell Technologies, Cambridge, MA, USA) gradients and
centrifuged at 1200 Xg for 20 min at room temperature RT using a Beckman J6-MI
centrifuge. After centrifugation, the plasma was removed by aspiration and the buffy-coat
layer carefully transferred by quickly poured into a clean 50 ml conical tube (Falcon,
Oxnard, CA, USA). The buffy coat was washed 5 times with PBS followed by
centrifugation at 120 Xg for 10 min at RT. The viability of PBMCs was determined by
trypan blue exclusion assay using 0.4% trypan blue stain (Strober, 2001). The following
formula was used to calculate the cell viability of the monocytes:
Cell viability % = Number of viable cells (non-trypan blue stained cells-trypan blue
stained cells) X 100/Total counted cells.
The PBMC pellet was re suspended in RPMI 1640 medium (GE Healthcare, Hyclone
Laboratories, Logan, UT, USA) supplemented with 10% FBS, penicillin (100 U/ml) and
streptomycin (100μg/ml) to achieve a final concentration of 1X106 cells/ ml. The cells
were incubated in T175 Flask for 3 h at 37˚C (Corning, NY, USA).
Plastic adherence based monocyte separation and morphological identification
The monocytes were isolated by the plastic adhesion method (Mwangi et al.,
2005, Rajput, 2014) with modifications. Following incubation for 3 h at 37˚C, the
floating cells were discarded and flasks were washed 5 times with PBS how much?? and
the wash discarded. The adherent cells were detached with Accutase™ (eBioscience, San
Diego, CA, USA). Detached cells were washed two times by suspending them in PBS
and pelleting by centrifugation at 120 Xg for 10 min at RT. The detached cells were
identified as monocytes with a characteristic kidney shape nucleus by H&E stain. Briefly,
1 ml of the detached cells was concentrated on a Cytospin™ slide (Thermo Shandon,
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USA). The slide with the concentrated cells could dry for 15 min in the biosafety hood
then stained for 15 min using Mayer’s hematoxylin solution (Sigma-Aldrich, St. Louis,
MO, USA). The slide was rinsed with tap water and re stained with alcoholic solution of
eosin for 40 seconds (Sigma-Aldrich, St. Louis, MO, USA). Finally, the slide was double
rinsed with 96-100% ethanol?? Or methanol alcohol and the slide was examined under
oil emersion lens using an inverted compound microscope (Olympus, PA, USA).
Monocytes were counted 3 times and the average was taken. The purity of monocytes
was calculated as follow:
Monocyte % = Number of monocytes (kidney shape nucleus) X 100/Total counted cells.
Peripheral blood monocytes-derived macrophages (MDM) culture and characterization
MDM were cultured as described by Elmowalid, 2003 with modifications.
Briefly, the adherent monocytes were cultured in RPMI 1640 (GE Healthcare, Hyclone
Laboratories, Logan, UT, USA) supplemented with 10 % FBS, penicillin (100 U/ml) and
streptomycin (100μg/ml) at a final concentration of 1x 105 cells/ well in 48-well plate
followed by incubation for 7 days at 37˚C in CO2 incubator. The incubated cells were fed
every other day simply by replacing half of the conditioned media with fresh complete
RPMI. At the 7th day, the MDM were characterized phenotypically as MHCI, MHCII,
CD11b and CD14 positive for at least 84% of the cells. This was done as described by
Rajput, 2013. Briefly, MDM were detached using Accutase™ (eBioscience, San Diego,
CA, USA) followed by centrifugation for 10 min at 1000 Xg and washing with PBS. The
number of the cells was adjusted to 1x106/ml. Four primary mouse mAb antibodies for
MHC-I (H58A), MHC-II (H42A), CD11b (MM10A) and CD14 (MM61A) (Monoclonal
Antibody Center, WSU, Pullman, WA, USA) were used to characterize the cells. Cells
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were incubated with 50µl of diluted primary antibodies 1:100 in PBS containing 1% FBS
at 4°C for 10 min followed by washing with PBS. This was followed by staining with
1:1000 in PBS diluted FITC labeled anti-mouse secondary antibody (VMRD Inc.,
Pullman, WA, USA, containing 1% FBS, at 4°C for 10 min. The stained cells were
washed two times with PBS and were fixed with 200µl of 1% paraformaldehyde. The
percentage of cells expressing surface markers was calculated using BD Accuri™ C6
Plus Flow Cytometer (BD Biosciences, CA, USA).
BVDV infection of MDM
MDM was infected with 3 different strains of BVDV, 1373, 28508 and 296C in
triplicates as described by Elmowalid, 2003 with modifications. Briefly, the viral strains
were adjusted to infect MDM at multiplicity of infection (MOI) of 1 by diluting the virus
stock with plain RPMI 1640 medium. Seven-day old MDM washed with 1x PBS to
remove old medium containing floating dead cells then infected with diluted virus strain
with 1X105 TCID50 at MOI of 1 in a final volume of 100 µl. The infected cells were
incubated for 1 h then washed again to remove the excess unbound virus and 500 µl of
complete RPMI 1640 medium was added to each well. At least one column of the plate
was mock infected with complete RPMI 1640 medium as a negative control. The
infected MDM were incubated for 12, 24 or 48 h at 37°C in CO2 incubator.
Direct immunofluorescence assay
MDM infection with BVDV was monitored by direct immunofluorescence using
FITC-labeled BVDV-specific polyclonal antibody of swine origin (VMRD Inc., Pullman,
WA, USA) to confirm virus infection of MDM. The direct immunofluorescence was
done using the SOP provided by (ADRDL, SDSU, USA). Briefly, the infected MDM
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were air-dried then fixed by adding 100 µl of 20% acetone diluted in 1x PBS and
incubated at RT for 10 min. The acetone was discarded and 50 µl of FITC conjugated
BVDV-specific polyclonal antibody was added to each infected well as well as the mock
infected negative control that work to exclude nonspecific fluorescence signal, this in
addition to including un stained control by adding 50 µl of PBS. The whole plate was
incubated at 37°C for 30 min and the plate was examined using a fluorescent inverted
microscope (Olympus, PA, USA) (Figure 2.3).
Supernatant collection and irradiation
Supernatant collection and treatment was done as described by Elmowalid, 2003
with modifications. Briefly, the infected macrophage supernatants of the three BVDV
strains were collected at 12, 24 and 48 h pi in 15 ml conical tubes. The supernatant was
centrifuged at 1000 Xg for 10 min at RT to remove cellular debris. After dispensing each
strain supernatant in 100x15 mm polystyrene sterile square petri dishes (Falcon, Oxnard,
CA, USA), the supernatant was treated by UV irradiation at 15 cm for 20 min on ice to
inactivate virus (Perler et al., 2000; Jungmann et al., 2001). The absence of any infectious
viral particles in the treated supernatants was confirmed by IP assay and the result was
contrasted to a positive 1373 infected MDBK. Finally, three different time point; 12, 24
and 48h UV-irradiated-supernatants for each strain of BVDV were used either directly
for treatment of lymphocytes or aliquot and stored at -20°C (Figure 2.4).
Quantification of apoptosis-related cytokines by qRT-PCR of BVDV-infected MDM
RNA was harvested using the methods described by Rajput, 2013 with modifications.
Briefly, the MDM infected with one of the 3 different strains of BVDV were collected at
2 different time points, 24 or 48 h pi, then washed 2 times with 1x PBS. The cells were
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lysed by freezing at -80°C for 15 minutes and thawing at 4°C for 30 minutes. The
washed, infected MDM were lysed and nucleic acid extraction done using RNeasy
extraction kit (Qiagen, Valencia, CA, USA). The washed cells were kept at -80˚C if they
were not extracted directly. A negative control using RNase, DNase free water
(Invitrogen, Life Technologies, Thermo Fisher Scientific, PA, USA) was included to
exclude any possible nucleic acid contamination every time NA extraction conducted.
The extracted NA of different samples was normalized to 5 ng/µl using Nanodrop ND1000 Spectrophotometer (Fisher Scientific, NH, USA). Around 2 µl of the normalized
NA was used to start relative quantification of apoptosis-related cytokines; TNF-a, IL-1a,
IL-1b and IL-6 for each sample in duplicates for each animal used in this study by using
quantitative reverse transcriptase PCR (qRT-PCR). MDM from at least 3 different
animals were used for infection with the one of three different strains of BVDV. qRTPCR was done in 25µl reaction using Power SYBR® Green RNA-to-Ct™ 1-Step Kit
(Thermo Fisher Scientific,, PA, USA). The quantification of cellular mRNA was done
using an ABI 7900HT High-Throughput Real-Time Thermocycler (Applied Biosystems,
Life Technologies, Thermo Fisher Scientific, PA, USA). The relative expression of
mRNA was standardized using beta actin as a housekeeping gene to ensure the PCR
efficiency via stable expression of the gene. Nucleic acid extracted from mock-infected
MDM with complete RPMI 1640 medium was used as a negative control. Nucleic acid
extracted from MDM treated with Concanavalin A (ConA) (Sigma-Aldrich, St. Louis,
MO, USA) was used as a positive control. ConA-treated macrophages up-regulate the 4
cytokines used in this study. The cytokine primers used were described by Konnai et al.,
2003 (Table 2.2). The qRT-PCR results were expressed as cycle threshold (CT) values;
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the CT value is the number of PCR cycles that is required to obtain the threshold
detection. Each qPCR experiment was followed by heat dissociation curve step to verify
the result and to exclude nonspecific amplification. qRT-PCR results were analyzed using
relative expression software tool (REST©2009 software) (Pfaffl et al., 2002).
Fresh lymphocyte culture
The PBMCs were isolated as described above and monocytes removed by
adhesion to plastic for 3 h at 37°C in CO2 incubator. The non adhesive cells were
collected and washed 3 times by PBS and centrifuged at 120 Xg for 10 min at RT to
remove the platelets. The pelleted lymphocytes were suspended in RPMI 1640 medium
supplemented with 15% FBS, penicillin (100 U/ml) and streptomycin (100μg/ml) to
achieve final concentration of 1x 105 cells/ ml followed by culturing in 24-well plate with
a seeding density of 1 ml/well. The plate then incubated at 37°C till either direct infection
with BVDV strains or treatment with infected macrophage supernatant.
Examining the direct, indirect and the combined effect of BVDV strains on peripheral
blood lymphocyte population
To examine the indirect effect of BVDV strains, peripheral blood lymphocytes
were treated with 12, 24 or 48 h irradiated supernatants from BVDV-infected
macrophages at a dilution of 1:1 and incubated for 12, 24 and 48 h post treatment as
described by Elmowalid, 2003.
To examine the direct effect of BVDV strains, peripheral blood lymphocytes were
infected with 1373 and 296C strains as described by Ridpath et al., 2007 with
modifications. Briefly, the viruses were diluted using RPMI 1640 medium and adjusted
to infect the lymphocytes at MOI of 1. This is followed by incubation for 1 h then the
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plate was spun down for 10 min at 400 Xg and the excess virus was discarded. This was
followed by re suspension of the infected lymphocyte pellet in complete RPMI medium,
so that each well contain 1 ml of cell suspension, then incubation for 12, 24 and 48 h post
infection.
To investigate whether the indirect effect had a synergistic effect with the direct
effect on the lymphocyte apoptosis, we studied the combined effect of both direct and
indirect apoptotic effect of 296C strain of BVDV. Briefly, 2 parts of the infected MDM
48h supernatant of 296C strain was added to one part of the diluted virus (MOI:1) and
one part of 1x105 lymphocytes suspended in 100µl of complete RPMI 1640 medium.
Virus-lymphocyte mixture was incubated for 24 h at 37˚C in CO2 incubator. We included
also the direct effect alone as well as the indirect effect to compare between the 3
different effects: direct, indirect and the combined. Mock-infected controls were also
included to exclude virus non-specific apoptosis simply by suspending the lymphocytes
with complete RPMI 1640 medium.
BL-3 culture and infection
The BL-3 cell line was cultured and handled as described by Ridpath et al., 2006
with modifications. Briefly, the BVDV-free BL-3 cells were obtained kindly from Dr.
Shollie Falkenberg and were propagated in suspension culture in RPMI 1640 medium
(GE Healthcare, Hyclone Laboratories, Logan, UT, USA) supplemented with 15%FBS,
penicillin (100 U/ml) and streptomycin (100μg/ml) to achieve final concentration of 1x
106 cells/ ml. T-25 flasks were used for incubation with each flask containing 30 ml cell
suspension and incubated in an upright position in CO2 incubator for 3 days at 37°C. The
cells were sub-cultured using the protocol of Ridpath et al., 2006, by removing 2 parts of
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the cell suspension and replacing with fresh complete RPMI 1640. The BL-3 cells were
then cultured in 24-well plates (Falcon, Oxnard, CA, USA) at a seeding density of 1x105
cells/ well. BL-3 cells were then treated indirectly or infected directly as described above
for fresh lymphocytes.
Virus neutralization
Each viral strain was diluted to MOI of 1 and incubated at 37°C for 1 h with
either Erns specific 15c5 monoclonal antibody, 1mg/ml (IDEXX Laboratories, Westbrook,
ME, USA) or with BVDV-specific polyclonal antibody (Kindly supplied by Dr. Fulton,
Food Animal Research, Oklahoma State University) in a parallel experiment. The
polyclonal antibody was previously examined for its neutralization effect against each of
the 3 BVDV strains used and it was higher than >1:512 (data not shown). The BL-3 cell
line was seeded at 1x105 and allowed to be incubated with the virus-antibody mixture at
37˚C for 36 h post treatment in CO2 incubator.
Supernatant neutralization
Twenty-four hour (24h) or 48h supernatants from the BVDV-infected
macrophages with one of the three different strains was incubated at 37°C for 1h with Erns
specific 15c5 monoclonal antibody (IDEXX Laboratories, Westbrook, ME, USA) or with
BVDV-polyclonal antibody (Kindly supplied by Dr. Robert Fulton, Food Animal
Research, Oklahoma State University) in a parallel experiment. The mixture of the
infected supernatant and antibody was prepared as 2 parts of infected supernatant
incubated with one part of concentrated antibody. Three (3) parts of the
supernatant/antibody mixture was added to one part of BL-3 cell line seeded at 1x105
cells/well, followed by incubation at 37˚C for 36 h post treatment.
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Apoptosis analysis using Annexin V staining
This was done using the AnnexinV staining kit (eBioscience, San Diego, CA,
USA). Briefly the infected or supernatant treated lymphocytes was washed once with 1X
PBS and the cells were spun down at 1000 Xg for 10 min and re suspended in 100µl of
1X binding buffer supplied by the kit as 4X stock solution. Five (5) µl of FITC
conjugated annexin v antibody added to the lymphocytes suspended in 100µl of binding
buffer and incubated for 10 min in dark. This was followed by washing the cells twice by
suspending the cells in 1X binding buffer followed by centrifugation of the cells at 1000
Xg for 10 min. Five (5) µl of propidium iodide was added to the washed cells and the
cells suspending in 1X binding buffer followed by centrifugation of the cells at 1000 Xg
for 10 min. Finally, the washed cells were re suspended in 200µl of 1X BD FACS™
lysing solution followed by analysis with BD Accuri™ C6 Plus Flow Cytometer (BD
Biosciences, CA, USA). The result was expressed as % of apoptosis
Statistical analysis
Data was analyzed using a student’s t-test (Microsoft EXCEL, MAC 2011) to
assess the significance of the differences between mean values of treated and control
samples at each time point. Differences were considered significant at P <0.05. Every
experiment was achieved using at least 3 animals (replicates) and 3 repeats (performed 3
times for each replicate animal) to confirm the reproducibility of the methods used. The
variations in results were calculated by standard deviation at each time point. For
cytokine analysis, REST © 2009 that is based on analysis of variance (AVOVA).
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RESULTS
Monocyte identification and MDM characterization
H&E staining of cells isolated using adherence as positive selection revealed
characteristic mononuclear cells with kidney shaped nucleus with morphological
characteristics of bovine monocytes with a purity of 88%±4 (Figure 2.1). Following
maturation, the MDM purity ranged from 84 to 96%±2.6 by flow analysis using
macrophage-specific surface markers. Flow analysis indicated MDM expression of 98.57
% MHCI, 97.25 % MHCII, 84.34% CD11b and 90.24% CD14 (Figure 2.2).
BVDV infection of MDM
The infected macrophages had BVDV-specific intra-cytoplasmic staining by
direct immunofluorescence at12 h post infection for all 3 strains (Figure 2.3A, B, C). The
mock infected negative control had no BVDV marked cytoplasmic fluorescent signal
(Figure 2.3D).
Inactivation of infected supernatant
The infected MDM supernatant was UV irradiated to inactivate infectious BVDV
particles to exclude direct effect of the virus. To check for the success of irradiation,
MDBK cells were treated with irradiated supernatant and this was followed by
immunoperoxidase (IP) assay to detect virus replication. The results of IP assay with UVirradiated virus showed a complete absence of IP staining (Figure 2.4A) compared to the
positive IP staining of 1373-infected-MDBK control (Figure 2.4B).
Role of cytokines in the indirect lymphocyte apoptosis
Quantitative RT-PCR for the infected MDM lysate at 3 different time points; 12,
24 and 48 h post infection was performed. The apoptosis-related cytokines didn't show
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significant change at any of the three time points compared to negative mock-infected
control. The positive Con A treated MDM lysate showed significant up-regulation
comparing to negative mock-infected control (Figure 2.5.)
Indirect lymphocyte apoptosis and flow analysis
Three time-point supernatants from 12, 24 and 48h BVDV-infected macrophages
with 3 different strains of BVDV were used to treat fresh peripheral blood lymphocytes
or BL-3 cell line. The 12 h supernatants of all strains didn't show any significant
apoptosis from the mock-infected control (Figure 2.6A). Both 24 and 48 h supernatants
of both high virulent 1373 and virulent 296C resulted in apoptotic effect on the both fresh
and BL-3 lymphocytes (p<0.05) (Figures 2.6B, C; 2.7A, B C). All supernatants from 12
thru 48h of the low virulent NCP 28508 didn't show any significant apoptotic change
from the mock infected control for either BL-3 lymphocytes or peripheral blood total
lymphocyte population (Figure 2.6B, C)
Direct lymphocyte apoptosis and flow analysis
The direct infection of lymphocytes either from peripheral blood or BL-3 cell line
varied based on the biotype of BVDV (Figure 2.8). CP 296c led to a marked and
significant apoptosis (p<0.01) from 12 h pi of 19±4.2% which increased to 44±6.5%
through 48 h pi compared to 7.5% and 18% at 12 and 48 respectively for the mockinfected controls. However, both NCP high virulent 1373 and low virulent 28508 strains
didn't induce significant changes (p<0.05) compared to the mock-infected control until 48
h post infection (Figure 2.8.). A comparison between the direct and indirect effect of high
virulent 1373 strain was conducted and the indirect effect at 24 and 48h supernatant was
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2-3 times greater than the direct effect (Figure 2.9). The direct effect was not
significantly different from the mock-infected control (Figure 2.9)
The combined effect of 296C and its infected MDM supernatant on lymphocyte apoptosis
296C induced a marked direct as well as indirect apoptotic effect on lymphocyte
population Figure 2.10). To investigate whether these 2 effects could be synergistic or
antagonistic, the BL-3 lymphocytes were treated with supernatant of infected MDM with
296C along with direct infection with the virus in the same well. The results showed that
there was no significant difference in the percentage of lymphocyte apoptosis induced by
the direct effect alone compared to the combined effect (Figure 2.10). However, the
combined effect induced more lymphocyte apoptosis but not significantly different (p =
0.055) than the indirect effect of 296C alone (p<0.05) (Figure 2.10).
Role of Erns glycoprotein in the indirect lymphocyte apoptosis
To investigate which viral factors were responsible for the indirect lymphocyte
apoptosis, 15c5 Erns specific mAb was used to neutralize the supernatant of infected
MDM of the CP 296C or NCP 1373 strain of BVDV. Following neutralization, the BL-3
cells were treated with the neutralized infected supernatant of one of these 2 strains and
the percentage of lymphocyte apoptosis was calculated by FACS analysis. There was no
significant difference in the percentage of lymphocyte apoptosis between that infected
supernatant treated with mAb and the untreated for both strains. The mAb-treated or
untreated 24 and 48h supernatant induced significant lymphocyte apoptosis (p<0.05) that
ranged from 15.35±5.62 to 18.1±4.33% for 24h supernatant and from 27±1.4 to 29±3.7%
for 48h supernatant. They were all significantly different compared to the mock-infected

69
cells that only induced around 5.45±3.23 to16±2.3% at 36 h post treatment (Fig 2.11A &
B).
Role of other viral proteins in lymphocyte apoptosis
The role that any other viral proteins could plat in the indirect lymphocyte apoptosis was
determined using apoptosis neutralization test. Infected MDM supernatant of either 1373
or 296C was further treated with BVDV-specific polyclonal antibody and the apoptotic
effect was measured by FACS analysis. Like Erns mAb, BVDV polyclonal antibody failed
to protect against apoptosis in BL-3 cells (Fig 2.11A & B). Polyclonal antibody-treated
supernatant induced similar levels of apoptosis as that induced by supernatant alone with
either BVDV strains. The percentage of apoptosis was almost the same as that obtained
from mAb data (Fig 2.11A & B).
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DISCUSSION
This study sheds light on the role of macrophages in the process of lymphoid
apoptosis associated with BVDV infection. Highly virulent BVDV strains can induce
both direct and indirect apoptosis on lymphocyte populations regardless of the biotype
the strains. These results differ from the results reported by Zhang and his group that
only CP BVDV strains can induce apoptosis (Zhang et al., 2016). This difference is
probably due to the usage of different strains. Our results are consistent with the results of
Pedrera et al., 2009 that did not relate the apoptotic effect to the biotype of the strain. Our
results support the results of Ridpath et al., 2006 that NCP high virulent 1373 strain can
induce lymphocyte cytopathogenesis (apoptosis). This third biotype, lymphocytopathogenic is unique since cytopathology is only induced in lymphocytes while 1373
remains NCP on susceptible non-lymphoid cell lines (Ridpath et al., 2006).
In the current study, we found that at least one virulence factor of 1373 BVDV
strain is probably associated with the severe lymphoid depletion as low virulent 28508
failed to induce apoptosis on the fresh lymphocytes. Our results agree with the
association between virulence and the degree of immune suppression that is associated
with lymphoid depletion in vivo (Ammari et al., 2012, Falkenberg 2014).
The role of macrophages in lymphocyte apoptosis was investigated in this study.
Our results suggested that the supernatant of infected macrophages with only virulent
BVDV strains induced lymphocyte apoptosis. These results provide an explanation to the
observation that there are increased number of macrophages 3 days post infection prior to
lymphoid depletion (Pedrera et al., 2009). Moreover, this indirect effect mediated by
macrophages wasn't significant until 24 h post infection with virulent BVDV strains,
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suggesting limiting the infection would decrease or prevent the severe immune
suppression induced by BVDV.
In contrast, the CP strain of BVDV was capable of induction of a fast and direct
apoptotic effect on lymphocytes comparing to the NCP virulent strain. The NCP BVDV
didn't exert any direct apoptotic effect until as late as 3 days’ post infection which is
consistent with the late apoptotic effect of 1373 as a lympho-cytopathogenic biotype of
BVDV (Ridpath et al., 2006). Interestingly, we noticed that high virulent 1373 strain of
BVDV induced more marked and faster apoptotic effect on indirectly as compared to the
direct effect. These results suggest that the severe and faster immune suppression
associated with high virulent 1373 is likely due to the indirect effect mediated by
macrophages.
Cytokines associated with apoptosis produced by BVDV-infected macrophages
do not appear to be involved in lymphocyte apoptosis. There was no significant change
in TNF- a, IL-1a, IL-1b or IL-6 mRNA levels. These results were different from those
described for CSFV as CSFV is capable of induction of both direct and indirect
lymphocyte apoptosis and TNF-a is involved in this process (Choi et al., 2004). Although
TNF induction appears to be an apoptotic mechanism for CSFV, this does not appear to
be true for BVDV. This lack of involvement of TNF-a is in agreement with previous
results that ruled out a role for TNF-a in BVDV lymphocyte apoptosis (Pedrera et al.,
2009).
Previously, it has been reported that Erns glycoprotein plays an important role in
the process of lymphocyte apoptosis induced by BVDV and CSFV (Bruschke et al.,
1997). However, the use of Erns specific monoclonal antibody with the infected
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macrophage supernatant in this study revealed that Erns glycoprotein doesn't play a
significant role in the indirect lymphocyte apoptosis. This difference may because they
used a cloned BVDV with Erns glycoprotein of CSFV but not the Erns of BVDV. We
have also ruled out the effect of other viral proteins on lymphocyte apoptosis using
BVDV-specific polyclonal antibodies. The polyclonal treated supernatant failed to
protect against indirect lymphocyte apoptosis. However, there was a protective effect
exerted by both Erns specific monoclonal and BVDV-specific polyclonal antibodies
against the direct apoptotic effect. This was likely due to blocking effect of these
antibodies which indicate they neutralize virus efficiently but the macrophage produced
lymphocyte apoptosis factor is probably not of viral origin.
The current work also has revealed that CP virulent 296 strain of BVDV can
induce both direct and indirect apoptotic effect on lymphocytes. This is in partial
agreement with previous work that proposed that lymphocyte apoptosis is associated with
the direct effect of the virus on the infected cell rather the interaction between infected
and normal cell (Zhang et al., 1996, Lambot et al., 1998). However, in a parallel
experiment, we have found that the sum of direct and indirect apoptotic effect of 296C
isn’t significantly different from the direct effect alone that probably indicate that the
indirect apoptotic effect of CP virulent strain of BVDV is not exaggerating the overall
apoptosis induced by that strain. Moreover, we have also noticed that while the additive
effect of both direct and indirect wasn't significant compared to the direct effect alone,
the direct effect was significant compared to the indirect effect. This data suggested that
CP virulent BVDV exerted its apoptotic effect on lymphocytes mainly via the direct
effect of the virus.
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The use of BL-3 cell line in this study was also useful as it gave similar results as
compared to peripheral blood lymphocytes. This finding with BL-3 cells was consistent
with what was reported previously of the apoptotic effect of high virulent BVDV strains
on the BL-3 cell line (Ridpath et al., 2016). The degree of apoptosis induced in the
lymphocytes of both peripheral blood or BL-3 cell line was almost the same. This
finding causes us to speculate that B cells are more likely to be affected than T
lymphocytes but this hypothesis needs to be tested.
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GENERAL CONCLUSION
BVDV is considered the cattle industry's most costly endemic viral diseases. As a
potent immunosuppressive agent, BVDV infection can lead to vaccination failure and
makes a whole farm susceptible to infection with other bovine pathogens. It was
important for our study to focus on immune dysfunction caused by BVDV through
apoptosis of specific lymphocytes that are important for clearance of the virus from the
body of infected animals. Our data suggested that the immune dysfunction associated
with high-virulent NCP 1373 strain was mainly due to the indirect effect mediated by
macrophages. Unlike high-virulent 1373, cytopathogenic BVDV strain 296C lymphoid
depletion was due to both direct and indirect effects, but the direct effect seems to be
more important. Unlike CSFV, neither TNF or Erns glycoprotein induce BVDV
lymphocyte apoptosis. This led us to hypothesis that the indirect lymphocyte apoptotic
effect of was likely mediated by host but not virus factors. Further we found that other
apoptosis-related cytokines that play an important role in the indirect apoptosis didn’t
seem to play a role in induction of indirect BVDV lymphocyte apoptosis.
Further investigation of the factors present in the supernatant of the infected
macrophages with high virulent strains need to be conducted so that we have better
understanding of the disease mechanism. This can lead to finding a way to block these
factors that can be used as a therapeutic practice in the acutely infected animals to help
improve recovery. Understanding these factors better would also help improve the
current control strategies and decrease the risk and the economic losses of BVDV.
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Fig 2.1. Isolated bovine monocytes: Bovine monocytes
stained with H&E showing kidney shape nucleus with
88±4.2% purity.
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Fig 2.2. Cultured bovine MDM: MDM expressing MHC I (98.57±0.73) (A),
MHC II (97.25±2.81) (B), CD11 b (84.34±3.89) (C), and CD14 (90.24±5.99)
(D)
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Fig 2.3. BVDV infection of MDM: Direct immunoflourescence assay showing BVDV infection
of MDM and intra-cytoplasmic replication of 1373 (A), 28508 (B), 296 C (C) and mock infected
(D)
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Fig 2.4. Successful irradiation of MDM infected sup: Immunoperoxidase
assay showing inactivation of 1373 infected MDM supernatant (A) comparing to
positive 1373 control intra-cytoplasmic replication
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Fig 2.5. Quantification of apoptosis-related cytokines mRNA: TNF-a (A), IL-6 (B), IL-1b (C)
and IL-1a (D): qRT-PCR result was plotted and expressed as ∆CT that represent the difference
between the gene of interest and the house keeping gene (b-actin) (*p<0.05).
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Fig 2.6. The indirect apoptotic effect of BVDV strains on peripheral blood total
lymphocytes: at 12 (A), 24 (B) and 48 (C) h post treatment by 3 different time-point
supernatants; 12, 24 and 48h sup of 3 different strains; 1373, 28508 and 296 C inn
addition to the mock infected MDM sup and non-treated lymphocytes. (* p<0.05, ** p<
0.01)
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Fig 2.7. The indirect apoptotic effect of BVDV strains on BL-3 cells: at
12, 24 and 48 h post treatment by 3 different time-point supernatants; 12 (A),
24 (B) and 48 h(C) sup of 2 different strains; 1373 and 296 C inn addition to
the mock infected MDM sup. (* p<0.05, ** p< 0.01)
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Fig 2.8. Direct apoptotic effect of BVDV strains on BL-3 cells: BL-3 infected with
both CP 296 C, NCP 1373 and 28508 at 12, 24 and 48 h pi compared to mock-infected
cells (*p<0.05, **p<0.01).
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Direct and direct effect on BL-3 cells induced by
1373 virus and its supernatant
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Fig 2.9. Direct and indirect apoptotic effect on BL-3 cells induced by 1373 virus and
its supernatant: BL-3 cells were treated or infected by 2 time-points supernatants; 24 and
48h sup or 1373 strain and this was compared to mock-infected cells (*p<0.05, **p<0.01).
† Significance was determined in contrast to non-infected control.
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The combined effect of 296 C
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Fig 2.10. The combined effect of 296 C strains: the combined effect: (both
direct and indirect), was compared to direct and indirect, each alone as well
as the mock infected control. † Significance was determined in contrast to
non-infected control. (*p<0.05, **p<0.01)
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Fig 2.11. The role of viral proteins on BL-3 lymphocyte indirect apoptosis: 2
different time-point supernatants; 24 (A) and 48 (B) sup of infected MDM with 2 diff
strains of BVDV; 1373 and 296 C were neutralized using 2 different antibodies; 15c5
Erns specific monoclonal antibody and BVDV specific polyclonal antibody. This is in
comparison to positive sup and mock infected BL-3 cells. This result obtained 36 h
post treatment (*p<0.05)
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BVDV strains

Biotype and Genotype

Virulence

References

1373

NCP BVDV-2

High virulence

Stoffregen et. al., 2000

28508

NCP BVDV-2

Low virulence
Carman et. al., 1998

296C

CP BVDV-2

Low virulence

Table 2.1. Different strains of BVDV used in the current study

Ridpath et al., 2006
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Cytokine
1

TNF-a

2

IL-1a

3

IL-1b

4

IL- 6

5

b-actin

Forward Primer
5’- 3’
AGA CCC CAG CAC CCA
GGA CTC G
GAT GCC TGA GAC ACC
CAA
CAA GGA GAG GAA
AGA GAC A
TCC AGA ACG AGT ATG
AGG
CGC ACC ACT GGC ATT
GTC AT

Reverse Primer
5’- 3’
GGA GAT GCC ATC TGT
GTG AGT G
GAA AGT CAG TGA TCG
AGG G
TGA GAA GTG CTG ATG
TAC CA
CAT CCG AAT AGC TCT
CAG
TCC AAG GCG ACG TAG
CAG AG

Annealing
Temp oC
55
53
53
52
60

Table 2.2. The set of primers used for quantifications of apoptosis-related cytokine mRNA

